dosing of tirzepatide Micro-Dosing) How Many Units Is 2.5

GLP-1 is clinically-proven to be one of the most effective medication for long-term results

The 10-month trial contract with Intellihealth began July 1 under a state program with Connecticut Innovations, the states venture capital program

The trial aimed to evaluate the effects of the GLP-1 receptor agonist semaglutide on adipose tissue quantity and distribution in individuals with HIV-associated lipohypertrophy over a 32-week period

Other GLP-1 receptor agonists include semaglutide (Wegovy for weight management, Ozempic for diabetes) and liraglutide (Saxenda for weight management, Victoza for diabetes), with semaglutide 2.4 mg demonstrating greater average weight loss than liraglutide 3.0 mg in clinical trials

Where lab data was thin or hidden, we said so plainly

Increased muscle loss A 2024 meta-analysis of GLP-1 medications found that ~25% of total weight loss results from lean mass rather than fat, likely due to insufficient protein intake and resistance training among participants in these studies 1